drugset
drugset / Trial / NCT00398151

To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)

NCT00398151 ↗

Phase 3 Completed 58 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the changes in proinflammatory markers (ltd4 in urine) and eosinophil from peripheral blood after newly initiated montelukast therapy.

Timeline

Start
2005-08-01
Primary completion
2006-01-18
Completion
2006-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified — —

Indications

asthma